Stock listing
ARX Stock Price, News, Filings & Events — Aroa Biosurgery Ltd
Selected listing: ARX · ASX · AUD · AU
This page tracks Aroa Biosurgery Ltd's ARX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARX:ASX. ARX:ASX is the stock-level entry point for investors researching Aroa Biosurgery Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aroa Biosurgery Ltd is a public company traded on the Australian market under the ticker ARX. The company has a market capitalization of approximately AUD 145.18 million. Aroa specializes in innovative biosurgery solutions, focusing on improving patient outcomes in surgical and wound care settings.

- Ticker
- ARX:ASX
- Asset type
- Stock
- Market cap
- $132.3M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
Aroa Biosurgery Ltd ARX:ASX stock context
This page tracks Aroa Biosurgery Ltd's ARX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARX:ASX. ARX:ASX is the stock-level entry point for investors researching Aroa Biosurgery Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aroa Biosurgery Ltd is a public company traded on the Australian market under the ticker ARX. The company has a market capitalization of approximately AUD 145.18 million. Aroa specializes in innovative biosurgery solutions, focusing on improving patient outcomes in surgical and wound care settings.
Latest news from Aroa Biosurgery Ltd
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
September 6, 2026
FY26 Full Year Results Presentation
May 25, 2026
ARX FY26 Preliminary Results
April 29, 2026
Symphony Randomised Control Trial Complete
March 29, 2026
AROA Business Update Presentation
February 2, 2026
Research Aroa Biosurgery Ltd
Aroa Biosurgery Ltd investor report
Review AI stock analysis and investor report context for ARX:ASX.
Aroa Biosurgery Ltd company profile
View the public company page for Aroa Biosurgery Ltd on 6ix.
Aroa Biosurgery Ltd news
Read company news and market updates connected to Aroa Biosurgery Ltd.
Aroa Biosurgery Ltd investor events
Find investor webinars, events, and replay context for Aroa Biosurgery Ltd.